New drug could unlock donor kidneys for hard-to-match patients
NCT ID NCT07539857
First seen Apr 21, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study tests whether belimumab, a drug that affects immune cells, can improve detection of antibodies that make it hard for some kidney patients to find a donor. About 25 highly sensitized adults waiting for a kidney transplant will receive a short course of belimumab. Researchers will check if this helps identify more compatible donors and reduces wait time for a transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Leiden University Medical Centre
Leiden, 2333 ZA, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.